These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29665536)

  • 21. Duplex ultrasound of the superficial femoral artery is a better screening tool than ankle-brachial index to identify at risk patients with lower extremity atherosclerosis.
    Flanigan DP; Ballard JL; Robinson D; Galliano M; Blecker G; Harward TR
    J Vasc Surg; 2008 Apr; 47(4):789-92; discussion 792-3. PubMed ID: 18280098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of Foot Oxygenation with Near-infrared Spectroscopy in Patients with Critical Limb Ischemia Undergoing Percutaneous Transluminal Angioplasty: A Pilot Study.
    Boezeman RP; Becx BP; van den Heuvel DA; Ünlü Ç; Vos JA; de Vries JP
    Eur J Vasc Endovasc Surg; 2016 Nov; 52(5):650-656. PubMed ID: 27614555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft.
    Farraj N; Srivastava A; Pershad A
    J Invasive Cardiol; 2009 Jun; 21(6):278-81. PubMed ID: 19494404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries.
    Piorkowski M; Freitas B; Steiner S; Botsios S; Bausback Y; Scheinert D; Schmidt A
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):89-95. PubMed ID: 25410147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective comparison of bilateral photoplethysmography versus the ankle-brachial pressure index for detecting and quantifying lower limb peripheral arterial disease.
    Allen J; Overbeck K; Nath AF; Murray A; Stansby G
    J Vasc Surg; 2008 Apr; 47(4):794-802. PubMed ID: 18381141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Quantification of the Deformations of the Femoropopliteal Segment: Percutaneous Transluminal Angioplasty vs Nitinol Stent Placement.
    Gökgöl C; Schumann S; Diehm N; Zheng G; Büchler P
    J Endovasc Ther; 2017 Feb; 24(1):27-34. PubMed ID: 28095767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
    JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective evaluation of using IVUS during percutaneous superficial femoral artery interventions.
    Hitchner E; Zayed M; Varu V; Lee G; Aalami O; Zhou W
    Ann Vasc Surg; 2015 Jan; 29(1):28-33. PubMed ID: 25194552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of the ipsilateral superficial femoral artery on iliac angioplasty.
    Kudo T; Rigberg DA; Reil TD; Chandra FA; Ahn SS
    Ann Vasc Surg; 2006 Jul; 20(4):502-11. PubMed ID: 16732446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery.
    Baril DT; Rhee RY; Kim J; Makaroun MS; Chaer RA; Marone LK
    J Vasc Surg; 2009 Jan; 49(1):133-8; discussion 139. PubMed ID: 19174252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.
    Tepe G; Laird J; Schneider P; Brodmann M; Krishnan P; Micari A; Metzger C; Scheinert D; Zeller T; Cohen DJ; Snead DB; Alexander B; Landini M; Jaff MR;
    Circulation; 2015 Feb; 131(5):495-502. PubMed ID: 25472980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after endovascular treatment of deep femoral artery stenosis: results in a consecutive patient series and systematic review of the literature.
    Dick P; Mlekusch W; Sabeti S; Amighi J; Schlager O; Haumer M; Minar E; Schillinger M
    J Endovasc Ther; 2006 Apr; 13(2):221-8. PubMed ID: 16643077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Areas under peripheral pulse waves: a potential marker of atherosclerotic changes.
    Peltokangas M; Verho J; Mattila VM; Romsi P; Vehkaoja A; Lekkala J; Oksala N
    Physiol Meas; 2018 Feb; 39(2):025003. PubMed ID: 29286004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.
    Grenville JL; Tan KT; Moshonov H; Rajan DK
    Vascular; 2015 Feb; 23(1):31-40. PubMed ID: 24695358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing accuracy of pulse transit time measurements by automated elimination of distorted photoplethysmography waves.
    van Velzen MHN; Loeve AJ; Niehof SP; Mik EG
    Med Biol Eng Comput; 2017 Nov; 55(11):1989-2000. PubMed ID: 28361357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.